News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders
ATAI Life Sciences
Greg McKee | CEO, Tryp Therapeutics
Tryp Therapeutics
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
Seelos Therapeutics
Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical
Mydecine Innovations Group
Optimi Health Aims to Expand its Shareholder Base
Optimi Health
Lobe Sciences Appoints Ilan Hayman to Advisory Board
Lobe Sciences
Entheon Biomedical Corp. Launches HaluGen's Psychedelics Genetic Test
Entheon Biomedical
Algernon Pharmaceuticals Announces Appointment of Global Expert Dr. Steven L. Wolf for DMT Stroke Program
Algernon Pharmaceuticals
NeonMind Developing Music Playlist for Psychedelic Therapy Sessions
NeonMind Biosciences Inc.
Core One Labs Vocan Expands Product Commercialization Team
Core One Labs Inc.
Myconic Capital Corp. Signs Letter of Intent for Acquisition of NY Ketamine Medical Practice, PLLC
Wellbeing Digital Sciences
Tryp Therapeutics Announces Listing on OTCQB and DTC Eligibility
Tryp Therapeutics
PsyBio Strengthens its Leadership Team with Appointment of Dr. Michael Spigarelli as Chief Medical Officer
PsyBio Therapeutics
MindMed Announces the Publication of New Data on Personalized MDMA Dosing
Mind Medicine (MindMed)
Mindset Pharma Announces Filing of Amended and Restated FS and MD&A for the Three and Six Month Period Ended December 31, 2020
Mindset Pharma
Tryp Therapeutics Appoints Greg McKee as Chief Executive Officer
Tryp Therapeutics
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.